Opening Asia for Russia

India to resume vaccine exports under COVAX in October

03.10.2021 115 просмотров

The Serum Institute of India plans to resume vaccine exports.

The Serum Institute of India plans to resume the export of coronavirus vaccines under the international COVAX mechanism in October. This was announced by the head of the instituteAdar Punawalla in his interview to the British newspaper Telegraph.

According to Adar Punawalla, initially the volume of deliveries after their resumption will be small. He added that by January 2022, once domestic demand is met, the Serum Institute of India will increase its supply.

new products,” the newspaper quoted the head of the institute.

In March, the Serum Institute of India, India's national coronavirus vaccine manufacturer, temporarily suspended exports of the Covishield vaccine, developed by the British-Swedish company AstraZeneca. The decision was made against the backdrop of a rapid increase in the incidence of coronavirus infection in the country. The institute also manufactures a vaccine by the American company Novavax.

Новости партнёров